Increased urine acylcarnitines in diabetic ApoE -/- mice: Hydroxytetradecadienoylcarnitine (C14:2-OH) reflects diabetic nephropathy in a context of hyperlipidemia-Reference-Cited by-同舟云学术

Increased urine acylcarnitines in diabetic ApoE -/- mice: Hydroxytetradecadienoylcarnitine (C14:2-OH) reflects diabetic nephropathy in a context of hyperlipidemia

Published:2017-05 Issue:1 Volume:487 Page:109-115
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Mirzoyan Koryun,Klavins Kristaps,Koal Therese,Gillet Marion,Marsal Dimitri,Denis Colette,Klein Julie,Bascands Jean-Loup,Schanstra Joost P.,Saulnier-Blache Jean-Sébastien

Funder

INSERM

European Union

Europe (ERASMUS MUNDUS, MEDEA)

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference29 articles.

1. Heart Protection Study Collaborative, MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial;Collins;Lancet,2003

2. Hypercholesterolemia–a determinant of renal function loss and deaths in IDDM patients with nephropathy;Krolewski;Kidney Int. Suppl.,1994

3. Dyslipidemia and the progression of renal disease in chronic renal failure patients;Cases;Kidney Int. Suppl.,2005